Butyrate attenuates diet-induced obesity and insulin resistance in mice and negatively regulates PPAR-γ expression and activity, thus promoting a change in lipogenesis toward lipid oxidation, thus stimulating oxidative metabolism in the liver and adipose tissue and increasing energy expenditure [36,37,38,39]. The gene discussed is PPARG; the disease is obesity disorder.